Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0356 Transporter Info
Gene Name	SLC41A3
Transporter Name	Magnesium transporter protein solute carrier family 41 member 3
Gene ID	54946
UniProt ID	Q96GZ6

Post-Translational Modification of This DT
Overview of SLC41A3 Modification Sites with Functional and Structural Information
Sequence	M D G T E T R Q R R L D S C G K P G E L G L P H P L S T G G L P V A S E D G A L R A P E S Q S V T P K P L E T E P S R E T T W S I G L Q V T V P F M F A G L G L S W A G M L L D Y F Q H W P V F V E V K D L L T L V P P L V G L K G N L E M T L A S R L S T A A N T G Q I D D P Q E Q H R V I S S N L A L I Q V Q A T V V G L L A A V A A L L L G V V S R E E V D V A K V E L L C A S S V L T A F L A A F A L G V L M V C I V I G A R K L G V N P D N I A T P I A A S L G D L I T L S I L A L V S S F F Y R H K D S R Y L T P L V C L S F A A L T P V W V L I A K Q S P P I V K I L K F G W F P I I L A M V I S S F G G L I L S K T V S K Q Q Y K G M A I F T P V I C G V G G N L V A I Q T S R I S T Y L H M W S A P G V L P L Q M K K F W P N P C S T F C T S E I N S M S A R V L L L L V V P G H L I F F Y I I Y L V E G Q S V I N S Q T F V V L Y L L A G L I Q V T I L L Y L A E V M V R L T W H Q A L D P D N H C I P Y L T G L G D L L G S S S V G H T A A V P R R C T A S P G W G L I Q P F I C T Q H L I V S L L S F Y F P F C L L A K T S I
PTM type	X-Methylation X-Phosphorylation X: Amino Acid

Methylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC41A3			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	273
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC41A3 Lysine 273 has the potential to affect its expression or activity.
Phosphorylation
Serine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC41A3			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 13 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC41A3			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	27
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 27 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC41A3			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	35
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 35 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC41A3			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	45
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 45 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC41A3			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 47 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC41A3			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 58 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC41A3			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	122
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 122 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC41A3			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	125
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 125 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC41A3			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	275
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Serine 275 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC41A3			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 28 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC41A3			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 49 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC41A3			[9] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	55
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 55 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC41A3			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	119
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 119 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC41A3			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	126
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 126 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC41A3			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC41A3 Threonine 130 has the potential to affect its expression or activity.

References
1	Large-scale global identification of protein lysine methylation in vivo. Epigenetics. 2013 May;8(5):477-85.
2	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
3	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
4	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
5	HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
6	Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes. Sci Rep. 2016 Apr 15;6:24491.
7	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
8	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
9	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
10	An Impaired Respiratory Electron Chain Triggers Down-regulation of the Energy Metabolism and De-ubiquitination of Solute Carrier Amino Acid Transporters. Mol Cell Proteomics. 2016 May;15(5):1526-38.
11	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
12	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
13	Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12130-5.
14	Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2918-27.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence